Drug
E7449 Alone
E7449 Alone: highest development phase Phase 1/2, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| E7449 alone NCT01618136 | Phase 1/2 | Malignant Solid Tumour |
Latest
No recent events.
Follow E7449 Alone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.